TNF and chronic obstructive pulmonary disease: Indeed, new strategies for the treatment of COPD focus on the development of anti-inflammatory drugs, including antagonists of cytokines such as tumor necrosis factor (TNF)-α [14] and interleukin (IL)-8 [15].